Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 13 min ago
Peer-reviewedCC BY 4.0International Journal of Molecular Sciences

Exploring the Neuroprotective Effects of Walnut (Juglans regia L.) Against Cognitive Impairment in Alzheimer’s Disease Through the MAPK-mTORC1-TFEB-Mediated Endolysosomal Pathway: A Network Pharmacology and Molecular Docking Approach

5 affiliations
  1. 1Department of Chinese Medicine, E-Da Cancer Hospital, Kaohsiung 82445, Taiwan
  2. 2Institute of Traditional Medicine, National Yang Ming Chiao Tung University, Taipei 11221, Taiwan
  3. 3School of Chinese Medicine for Post-Baccalaureate, I-Shou University, Kaohsiung 84001, Taiwan
  4. 4Department of Chinese Medicine, Institute of Traditional Medicine, National Yang Ming Chiao Tung University, Taipei 11221, Taiwan
  5. 5Linsen Chinese Medicine and Kunming Branch, Taipei City Hospital, Taipei 10450, Taiwan

Abstract

Alzheimer’s disease (AD) is a complex neurodegenerative disorder with multifaceted pathogenesis. Given the clinical need for multi-target interventions, this study elucidated the neuroprotective mechanisms of walnut (Juglans regia L.) against AD-related cognitive impairment. Methods: We characterized 25 bioactive constituents (fatty acids and ellagitannins) and constructed a protein–protein interaction (PPI) network. GO/KEGG enrichment, integrated with Ingenuity Pathway Analysis (IPA), deciphered pharmacological pathways, followed by molecular docking to evaluate ligand–target binding thermodynamics. Network analysis revealed that walnut phytochemicals synergistically modulate the MAPK-mTORC1-TFEB-mediated endolysosomal homeostasis pathway. Molecular docking indicated that ellagitannins (strictinin, pedunculagin, tellimagrandin I) exhibit robust affinities for upstream RAS/RAF/MEK kinases, suppressing pro-pathogenic signaling. Concurrently, gallic acid targeted ABCA1 and TFEB, promoting TFEB activation and nuclear translocation to enhance beta-amyloid clearance and lysosomal biogenesis. This study provides evidence that walnut attenuates AD pathology through “multi-component” reinforcement of the endolysosomal defense system, establishing a mechanistic foundation for walnut as a promising functional food.

Related

  1. The Role of Herbal Medicines in Cognitive Impairment: A Narrative Review of Neuroprotective Mechanisms and Therapeutic Perspectives
    Aekkhaluck Intharuksa, Anchalee Prasansuklab, Tachpon Techarang +3
    NutrientsPeer-reviewedCC BYFull textNutritionEurope PMC
  2. Cognitive-Enhancing and Neuroprotective Effects of a Combination Extract of Atractylodes macrocephala and Rumex acetosa Against Scopolamine-Induced Memory Impairment
    Dool-Ri Oh, Hwan Lee, Yonguk Kim +2
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0General medicineCrossref
  3. Combined metabolomics and network pharmacology explore the protective mechanism of bornyl acetate against cognitive impairment in chronic sleep-deprived mice
    Qing Lv, Meiya Zhang, Ruiling Sun +5
    Scientific ReportsPeer-reviewedCC BYFull textNeurologyDOAJ
  4. Neuroprotective Potential of the Edible Seaweed Pterocladiella capillacea: Bioactivity Coupled LC-MS/MS, Metabolomics Annotation, Validation, and Network Pharmacology
    Meicai Yue, Longjian Zhou, Wanrong He +6
    NutrientsPeer-reviewedCC BYFull textNutritionEurope PMC
  5. Network Pharmacology-Guided Identification of Orientin from Passiflora incarnata Reveals Neuroprotective Effects Against Glutamate-Induced Excitotoxicity Through Regulation of Calcium Homeostasis.
    Jinyoung Park, Muhammad Yasir, Eun-Taek Han +4
    International journal of molecular sciencesPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMC
BibTeX
@article{lin2026exploring,
  title = {{Exploring the Neuroprotective Effects of Walnut (Juglans regia L.) Against Cognitive Impairment in Alzheimer’s Disease Through the MAPK-mTORC1-TFEB-Mediated Endolysosomal Pathway: A Network Pharmacology and Molecular Docking Approach}},
  author = {Chih-Ting Lin and Kuan-Tso Chen and Yu-Chiang Hung},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  month = sep,
  doi = {10.3390/ijms27188288},
  url = {https://www.mdpi.com/1422-0067/27/18/8288},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Exploring the Neuroprotective Effects of Walnut (Juglans regia L.) Against Cognitive Impairment in Alzheimer’s Disease Through the MAPK-mTORC1-TFEB-Mediated Endolysosomal Pathway: A Network Pharmacology and Molecular Docking Approach
AU  - Chih-Ting Lin
AU  - Kuan-Tso Chen
AU  - Yu-Chiang Hung
PY  - 2026
DA  - 2026/09/17
JO  - International Journal of Molecular Sciences
DO  - 10.3390/ijms27188288
UR  - https://www.mdpi.com/1422-0067/27/18/8288
AB  - Alzheimer’s disease (AD) is a complex neurodegenerative disorder with multifaceted pathogenesis. Given the clinical need for multi-target interventions, this study elucidated the neuroprotective mechanisms of walnut (Juglans regia L.) against AD-related cognitive impairment. Methods: We characterized 25 bioactive constituents (fatty acids and ellagitannins) and constructed a protein–protein interaction (PPI) network. GO/KEGG enrichment, integrated with Ingenuity Pathway Analysis (IPA), deciphered pharmacological pathways, followed by molecular docking to evaluate ligand–target binding thermodynamics. Network analysis revealed that walnut phytochemicals synergistically modulate the MAPK-mTORC1-TFEB-mediated endolysosomal homeostasis pathway. Molecular docking indicated that ellagitannins (strictinin, pedunculagin, tellimagrandin I) exhibit robust affinities for upstream RAS/RAF/MEK kinases, suppressing pro-pathogenic signaling. Concurrently, gallic acid targeted ABCA1 and TFEB, promoting TFEB activation and nuclear translocation to enhance beta-amyloid clearance and lysosomal biogenesis. This study provides evidence that walnut attenuates AD pathology through “multi-component” reinforcement of the endolysosomal defense system, establishing a mechanistic foundation for walnut as a promising functional food.
SN  - 1422-0067
ER  -